Matches in SemOpenAlex for { <https://semopenalex.org/work/W3013090880> ?p ?o ?g. }
- W3013090880 endingPage "574" @default.
- W3013090880 startingPage "567" @default.
- W3013090880 abstract "• Periprosthetic joint infection (PJI) is one of the most serious complications of prosthetic joint implantations with significant morbidity and mortality. • One-stage replacement arthroplasty for the treatment of PJIs results in similar cure rate than two-stage replacement arthroplasty, but the antibiotic therapy duration is not well established. • Recent data reported successful results with a six-week antibiotic therapy for two-stage arthroplasty, while the experience is very limited for one-stage arthroplasty. • We aimed to evaluate the effectiveness of a short six-week antibiotic course in PJIs after one-stage exchange. • A six-week course of antibiotics for knee and hip PJIs treated with one-stage replacement arthroplasty had a satisfactory remission rate. One-stage replacement arthroplasty for treatment of periprosthetic joint infection (PJI) results in similar cure rate than two-stage (around 85–92%), but antibiotic therapy duration is not well established. The aim of this study was to evaluate the efficacy of a short six-week antibiotic course in periprosthetic joint infections after onstage exchange. Retrospective, observational study conducted at Orthopaedic Department of Cochin Hospital, Paris, between 1st January 2010 and 31 December 2015. Patients with a microbiologically proven PJI, treated with one-stage replacement and 6 weeks (+/1week) of antimicrobial therapy were included. Pearson's- χ 2 and Wilcoxon tests were used to compare categorical and continuous variables. Fifty patients with periprosthetic joint infections (42 hip, 8 knee PJI) treated with one-stage replacement arthroplasty were included. Median age was 69.3 years (IQR 24.5–97.4). Infections occurred after a mean of 36 months (IQR 1–216). Bone biopsy cultures were positive for Staphylococcus spp. in 29 patients (58%), Cutibacterium acnes in 19 (38%), Gram-negative bacilli in 6 (12%). Polymicrobial infections occurred in 12 (24%). Intravenous antibiotics were administered for a median of 11 days (IQR 4–45) and 46 patients (92%) were switched to an oral therapy. Medium follow-up was of 32 months (IQR 12–101). Overall remission rate was 90%. A six-week course of antibiotics in knee and hip PJIs treated with one-stage RA has a satisfactory remission rate in this open study. La reprise totale de prothèse (RTP) en un temps pour le traitement des infections ostéoarticulaires (IOA) sur prothèse montre des taux de rémission comparables au ceux en deux temps (85–92 %), mais la durée de l’antibiothérapie n’est pas encore bien déterminée. L’étude examinait l’efficacité de six semaines d’antibiothérapie dans les IOA sur prothèse après RTP en un temps. Étude observationnelle rétrospective réalisée dans le service d’orthopédie de l’hôpital Cochin, Paris, entre le 1 er janvier 2010 et le 31 décembre 2015. Étaient inclus les patients ayant une IOA sur prothèse, microbiologiquement prouvée, ayant bénéficier d’une RPT et d’une antibiothérapie pour 6 semaines (±1 semaine). Les variables catégorielles et continues étaient comparés respectivement par les tests de Pearson- χ 2 et de Wilcoxon. Cinquante patients porteurs d’une IOA sur prothèse (hanche = 42, genou = 8) traités par remplacement en un temps ont été inclus. L’âge médian était 69,3 ans (IQR : 24,5–97,4). Le délai moyen de survenue de l’infection était de 36 mois (IQR 1–216). Les principales bactéries identifiées étaient Staphylococcus spp. (58 %), Cutibacterium acnes (38 %), bacilles Gram-négatif (12 %). Il s’agissait d’infections polymicrobiennes dans 24 % des cas. Les antibiotiques étaient administrés par voie intraveineuse pendant en médiane 11 jours (IQR 4–45) poursuivis par voie orale chez 46 (92 %) patients. Le suivi médian était 32 mois (IQR 12–101). Le taux de rémission était de 90 %. Six semaines d’antibiothérapie dans les IOA sur prothèse après RTP en un temps ont un taux de rémission satisfaisant dans cette étude ouverte." @default.
- W3013090880 created "2020-04-03" @default.
- W3013090880 creator A5004203630 @default.
- W3013090880 creator A5005545439 @default.
- W3013090880 creator A5006085295 @default.
- W3013090880 creator A5011591762 @default.
- W3013090880 creator A5014403667 @default.
- W3013090880 creator A5024832341 @default.
- W3013090880 creator A5028194649 @default.
- W3013090880 creator A5032006641 @default.
- W3013090880 creator A5033274131 @default.
- W3013090880 creator A5048430823 @default.
- W3013090880 creator A5053580384 @default.
- W3013090880 creator A5054749619 @default.
- W3013090880 creator A5069049455 @default.
- W3013090880 creator A5087574508 @default.
- W3013090880 date "2020-10-01" @default.
- W3013090880 modified "2023-10-14" @default.
- W3013090880 title "Six-week antibiotic therapy after one-stage replacement arthroplasty for hip and knee periprosthetic joint infection" @default.
- W3013090880 cites W1543474898 @default.
- W3013090880 cites W1909802012 @default.
- W3013090880 cites W1966218947 @default.
- W3013090880 cites W1983255179 @default.
- W3013090880 cites W1991065463 @default.
- W3013090880 cites W2000220760 @default.
- W3013090880 cites W2006218177 @default.
- W3013090880 cites W2018364323 @default.
- W3013090880 cites W2022009287 @default.
- W3013090880 cites W2030075293 @default.
- W3013090880 cites W2034696628 @default.
- W3013090880 cites W2044688982 @default.
- W3013090880 cites W2054911871 @default.
- W3013090880 cites W2059893856 @default.
- W3013090880 cites W2078590678 @default.
- W3013090880 cites W2079575346 @default.
- W3013090880 cites W2095788230 @default.
- W3013090880 cites W2098011791 @default.
- W3013090880 cites W2099018662 @default.
- W3013090880 cites W2102823237 @default.
- W3013090880 cites W2114753700 @default.
- W3013090880 cites W2130261670 @default.
- W3013090880 cites W2130830821 @default.
- W3013090880 cites W2133495950 @default.
- W3013090880 cites W2163581302 @default.
- W3013090880 cites W2169026505 @default.
- W3013090880 cites W2170102112 @default.
- W3013090880 cites W2179887963 @default.
- W3013090880 cites W2257988318 @default.
- W3013090880 cites W2331210532 @default.
- W3013090880 cites W2530244383 @default.
- W3013090880 cites W2560256520 @default.
- W3013090880 cites W2571923308 @default.
- W3013090880 cites W2883137154 @default.
- W3013090880 cites W2943943679 @default.
- W3013090880 cites W57483582 @default.
- W3013090880 doi "https://doi.org/10.1016/j.medmal.2020.03.003" @default.
- W3013090880 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32284220" @default.
- W3013090880 hasPublicationYear "2020" @default.
- W3013090880 type Work @default.
- W3013090880 sameAs 3013090880 @default.
- W3013090880 citedByCount "7" @default.
- W3013090880 countsByYear W30130908802020 @default.
- W3013090880 countsByYear W30130908802021 @default.
- W3013090880 countsByYear W30130908802023 @default.
- W3013090880 crossrefType "journal-article" @default.
- W3013090880 hasAuthorship W3013090880A5004203630 @default.
- W3013090880 hasAuthorship W3013090880A5005545439 @default.
- W3013090880 hasAuthorship W3013090880A5006085295 @default.
- W3013090880 hasAuthorship W3013090880A5011591762 @default.
- W3013090880 hasAuthorship W3013090880A5014403667 @default.
- W3013090880 hasAuthorship W3013090880A5024832341 @default.
- W3013090880 hasAuthorship W3013090880A5028194649 @default.
- W3013090880 hasAuthorship W3013090880A5032006641 @default.
- W3013090880 hasAuthorship W3013090880A5033274131 @default.
- W3013090880 hasAuthorship W3013090880A5048430823 @default.
- W3013090880 hasAuthorship W3013090880A5053580384 @default.
- W3013090880 hasAuthorship W3013090880A5054749619 @default.
- W3013090880 hasAuthorship W3013090880A5069049455 @default.
- W3013090880 hasAuthorship W3013090880A5087574508 @default.
- W3013090880 hasBestOaLocation W30130908801 @default.
- W3013090880 hasConcept C141071460 @default.
- W3013090880 hasConcept C146357865 @default.
- W3013090880 hasConcept C151730666 @default.
- W3013090880 hasConcept C2776348710 @default.
- W3013090880 hasConcept C2777417762 @default.
- W3013090880 hasConcept C2778104916 @default.
- W3013090880 hasConcept C2778120723 @default.
- W3013090880 hasConcept C2778336525 @default.
- W3013090880 hasConcept C2908736133 @default.
- W3013090880 hasConcept C2993328841 @default.
- W3013090880 hasConcept C3020326648 @default.
- W3013090880 hasConcept C3020736514 @default.
- W3013090880 hasConcept C501593827 @default.
- W3013090880 hasConcept C71924100 @default.
- W3013090880 hasConcept C86803240 @default.
- W3013090880 hasConcept C89423630 @default.
- W3013090880 hasConceptScore W3013090880C141071460 @default.
- W3013090880 hasConceptScore W3013090880C146357865 @default.